This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Devoe, D. J. Articles by Gitelman, S. E. Search for Related Content PubMed PubMed Citation Articles by Devoe, D. J. Articles by Gitelman, S. E.

Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing’s Disease¹

Departments of Pediatrics (D.J.D., W.L.M., F.A.C., S.L.K., M.M.G., S.M.R., S.E.G.) and Neurosurgery (C.B.W.), University of California, San Francisco, California 94143

Address all correspondence and requests for reprints to: Dr. Stephen E. Gitelman, Department of Pediatrics, University of California, 500 Parnassus Avenue, MU 405E, Box 0136, San Francisco, California 94143-0136. E-mail: sgitelma{at}PEDS.UCSF.EDU

Cushing’s disease refers specifically to an ACTH-producing pituitary adenoma that stimulates excess cortisol production. Trans-sphenoidal surgery is the treatment of choice in children and adolescents, but disparate cure rates have been reported, ranging from 50–98%. The discrepancies in cure rate are due primarily to the technical success of the surgery and the length and method of follow-up. We studied 42 consecutive children and adolescents (age, 18 yr) who underwent transsphenoidal exploration for the primary treatment of Cushing’s disease at University of California-San Francisco from 1974–1993. Only 7 patients had persistent disease, defined as evidence of Cushing’s disease within 6 months of surgery, yielding an initial remission rate of 83%. We comprehensively evaluated 26 of the 35 patients who experienced an initial remission, including testing of the ACTH-adrenocortical axis. The mean duration of follow-up is 7.2 yr (range, 1.5–13.6 yr). Seven experienced a relapse of Cushing’s disease, yielding a net remission rate of 73%. Relapses occurred an average of 4.2 yr postoperatively (range, 0.75–6.2 yr). Five patients experienced relapse within 5 yr of surgery, whereas 2 relapsed more than 5 yr postoperatively. Repeat transsphenoidal surgery was performed in 8 patients with persistent or recurrent disease, and 6 of these remain in remission. Low serum or urinary cortisol measurements within the first post-operative week predicted remission of Cushing’s disease, but were not necessarily predictive of long-term cure. Hypercortisolism had significant effects on bone metabolism, as reflected by both diminished bone density in the majority of patients examined and decreased growth rate. Both parameters improved after surgical care, although they did not fully normalize. We conclude that transsphenoidal surgery is a safe and effective treatment for pediatric Cushing’s disease, but long-term surveillance is necessary to detect possible recurrences.

This article has been cited by other articles:

				M. B. Lodish, N. Sinaii, N. Patronas, D. L. Batista, M. Keil, J. Samuel, J. Moran, S. Verma, J. Popovic, and C. A. Stratakis Blood Pressure in Pediatric Patients with Cushing Syndrome J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2002 - 2008. [Abstract] [Full Text] [PDF]

				L F Chan, H L Storr, P N Plowman, L A Perry, G M Besser, A B Grossman, and M O Savage Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy Eur. J. Endocrinol., April 1, 2007; 156(4): 477 - 482. [Abstract] [Full Text] [PDF]

				R T Netea-Maier, E J van Lindert, M den Heijer, A van der Eerden, G F F M Pieters, C G J Sweep, J A Grotenhuis, and A R M M Hermus Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease. Eur. J. Endocrinol., May 1, 2006; 154(5): 675 - 684. [Abstract] [Full Text] [PDF]

				H. L Storr, F. Afshar, M. Matson, I. Sabin, K. M Davies, J. Evanson, P N. Plowman, G M. Besser, J. P Monson, A. B Grossman, et al. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease Eur. J. Endocrinol., June 1, 2005; 152(6): 825 - 833. [Abstract] [Full Text] [PDF]

				D. P. Merke, J. N. Giedd, M. F. Keil, S. L. Mehlinger, E. A. Wiggs, S. Holzer, E. Rawson, A. C. Vaituzis, C. A. Stratakis, and G. P. Chrousos Children Experience Cognitive Decline Despite Reversal of Brain Atrophy One Year After Resolution of Cushing Syndrome J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2531 - 2536. [Abstract] [Full Text] [PDF]

				F A Stuart, T Y Segal, and S Keady Adverse psychological effects of corticosteroids in children and adolescents Arch. Dis. Child., May 1, 2005; 90(5): 500 - 506. [Abstract] [Full Text] [PDF]

				H. L. Storr, A. M. Isidori, J. P. Monson, G. M. Besser, A. B. Grossman, and M. O. Savage Prepubertal Cushing's Disease Is More Common in Males, But There Is No Increase in Severity at Diagnosis J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3818 - 3820. [Abstract] [Full Text] [PDF]

				G. A. F. S. Rollin, N. P. Ferreira, M. Junges, J. L. Gross, and M. A. Czepielewski Dynamics of Serum Cortisol Levels after Transsphenoidal Surgery in a Cohort of Patients with Cushing's Disease J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1131 - 1139. [Abstract] [Full Text] [PDF]

				T. Moshang Jr. Cushing's Disease, 70 Years Later ... and the Beat Goes on J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 31 - 33. [Full Text] [PDF]

				H. L. Storr, P. N. Plowman, P. V. Carroll, I. Francois, G. E. Krassas, F. Afshar, G. M. Besser, A. B. Grossman, and M. O. Savage Clinical and Endocrine Responses to Pituitary Radiotherapy in Pediatric Cushing's Disease: An Effective Second-Line Treatment J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 34 - 37. [Abstract] [Full Text] [PDF]

				A. Lienhardt, A. B. Grossman, J. E. Dacie, J. Evanson, A. Huebner, F. Afshar, P. N. Plowman, G. M. Besser, and M. O. Savage Relative Contributions of Inferior Petrosal Sinus Sampling and Pituitary Imaging in the Investigation of Children and Adolescents with ACTH-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5711 - 5714. [Abstract] [Full Text] [PDF]

				A. J. Espay, B. Azzarelli, L. S. Williams, and J. B. Bodensteiner Recurrence in Pituitary Adenomas in Childhood and Adolescence J Child Neurol, May 1, 2001; 16(5): 364 - 367. [Abstract] [PDF]

				J. Lindholm, S. Juul, J. O. L. Jørgensen, J. Astrup, P. Bjerre, U. Feldt-Rasmussen, C. Hagen, J. Jørgensen, M. Kosteljanetz, L. O. Kristensen, et al. Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 117 - 123. [Abstract] [Full Text]

				L. A. Soyka, W. P. Fairfield, and A. Klibanski Hormonal Determinants and Disorders of Peak Bone Mass in Children J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 3951 - 3963. [Full Text]

				M.-C. Lebrethon, A. B. Grossman, F. Afshar, P. N. Plowman, G. M. Besser, and M. O. Savage Linear Growth and Final Height after Treatment for Cushing's Disease in Childhood J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3262 - 3265. [Abstract] [Full Text]